Zackary S. Irani, Chief Executive Officer at BIOMERICA INC (BMRA), bought 31,250 shares at $1.60 ($50K) on 2026-08-26, disclosed to the SEC on 2026-08-27.
CEO Irani Zackary S. purchased $50,000 of stock at $1.60, signaling confidence in the company's valuation following a significant recent rally. This buy comes as the stock has surged over 28% in the last five days, suggesting the CEO views the current dip as a buying opportunity.
The stock has rallied 28.44% over the past five days and 23.8% over the last 30 days, but remains down 34.76% over the last year and is currently 37.92% below its 52-week high of $3.31.
1) Q4 earnings on 2026-02-26 (based on next_earnings_date); 2) Henry Schein collaboration to promote inFoods IBS test announced on 2025-10-17.
The stock is currently trading 40.27% above its 52-week low of $1.465, indicating a potential pullback risk if the recent momentum fades.
Something here stands out, but not much.
| Filing → |
| BMRA | BUY | 2023-05-12 | $635 | — | Filing → |
| BMRA | BUY | 2023-05-10 | $417 | — | Filing → |
| BMRA | BUY | 2023-05-05 | $1K | — | Filing → |